Vinayak Khattar,  —

Recent Posts

• Orelabrutinib reduces brain lesions in RRMS by 90% in Phase 2 trial
• 31 Days of MS: How could I forget the date of my first MS symptoms?
• Sleep disorders in MS women may be factor in cognitive decline: Study